More ubiquitous effects from non‐pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta‐analysis examining six core symptoms
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
This study aimed to characterize and compare the efficacy profile on six fibromyalgia syndrome (FM) core symptoms associated with pharmacologic and non‐pharmacologic treatments. We screened P ub M ed, E mbase and the C ochrane L ibrary for FM articles from 1990 to S eptember 2012 to analyse randomized controlled trials comparing pharmacologic or non‐pharmacologic treatments to placebo or sham. Papers including assessments of at least 2 of the 6 main FM symptom domains – pain, sleep disturbance, fatigue, affective symptoms (depression/anxiety), functional deficit and cognitive impairment – were selected for analysis. Studies exploring pharmacologic approaches (n = 21) were mainly dedicated to treating a small number of dimensions, mostly pain. They were of good quality but were not prospectively designed to simultaneously document efficacy for the management of multiple core FM symptom domains. Only amitriptyline demonstrated a significant effect on as many as three core FM symptoms, but it exhibited many adverse effects and was subject to early tachyphylaxis. Studies involving non‐pharmacologic approaches (n = 64) were typically of poorer quality but were more often dedicated to multidimensional targets. Pool therapy demonstrated significant effects on five symptom domains, repetitive transcranial magnetic stimulation on four domains, balneotherapy on three domains and exercise, cognitive behaviour therapy and massage on two domains each. Differences between pharmacologic and non‐pharmacologic approaches may be related to different modes of action, tolerability profiles and study designs. Very few drugs in well‐designed clinical trials have demonstrated significant relief for multiple FM symptom domains, whereas non‐pharmacologic treatments with weaker study designs have demonstrated multidimensional effects. Future therapeutic trials for FM should prospectively examine each of the core domains and should attempt to combine pharmacologic and non‐pharmacologic therapies in well‐designed clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
WOLFE, F., CLAUW, D. J., FITZCHARLES, M.-A., GOLDENBERG, D. L., HÄUSER, W., KATZ, R. S., MEASE, P., RUSSELL, A. S., RUSSELL, I. J., & WINFIELD, J. B. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100594 · Cited by 1,499
Self-citationAn internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865 · cited 1×
“Pain is a universal and nearly constant symptom, whereas other manifestations tend to be less prevalent and can vary in severity over time (Bennett et al., 2007).”
BackgroundSelf-citationEULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Self-citationArnold, L. M., Lu, Y., Crofford, L. J., Wohlreich, M., Detke, M. J., Iyengar, S., & Goldstein, D. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20485 · Cited by 624 · cited 1×
“Duloxetine studies provided data to analyse across all domains (Arnold et al., 2004, 2005, 2010).”
BackgroundGrossman, P., Tiefenthaler-Gilmer, U., Raysz, A., & Kesper, U. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000101501 · Cited by 505
Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain · doi:10.1016/j.pain.2005.06.031 · Cited by 471 · cited 1×
“Duloxetine studies provided data to analyse across all domains (Arnold et al., 2004, 2005, 2010).”
BackgroundGuidelines on the management of fibromyalgia syndrome – A systematic review
Häuser, W., Thieme, K., & Turk, D. C. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2009.01.006 · Cited by 347 · cited 2×
“Some combination of multicomponent therapy, consisting of pharmacologic and non-pharmacologic treatments, has been recommended to improve the efficacy of FM treatment (Häuser et al., 2010).”
BackgroundPsychological treatments for fibromyalgia: A meta-analysis
Glombiewski, J. A., Sawyer, A. T., Gutermann, J., Koenig, K., Rief, W., & Hofmann, S. G. (2010) · Pain · doi:10.1016/j.pain.2010.06.011 · Cited by 341
Behavioral Insomnia Therapy for Fibromyalgia Patients: A Randomized Clinical Trial
Edinger, J. D., Wohlgemuth, W. K., Krystal, A. D., & Rice, J. R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2527 · Cited by 330 · cited 2×
“CBT treatment was effective at improving all symptom domains except affective symptoms (Soares, 2002; Edinger et al., 2005; Thieme et al., 2006; Grossman et al., 2007; Falcao, 2008; Lera et al., 2009; Ang et al., 2010; Hsu et al., 2010; van Koulil et al., 2010; Carleton et al., 2011; Miró, 2011;…”
Background
Cited by
EULAR revised recommendations for the management of fibromyalgia
Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Fluß, E., Choy, E., Kosek, E., Amris, K., Branco, J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209724 · Cited by 1,566
Self-citationFibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 793
Häuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.22 · Cited by 505
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 275
Pérez-Aranda, A., Feliu-Soler, A., Montero-Marín, J., García-Campayo, J., Andrés-Rodríguez, L., Borràs, X., Rozadilla-Sacanell, A., Peñarrubia-Maria, M. T., Angarita-Osorio, N., McCracken, L. M., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001655 · Cited by 98
Metadata
- Authors
- Perrot, S., & Russell, I. J.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2014-08-19
- Volume
- 18
- Issue
- 8
- Pages
- 1067-1080
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W1524990180
- Cited by
- 106
- References
- 33
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: More ubiquitous effects from non‐pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta‐analysis examining six core symptoms. https://app.cochat.ai/papers/10.1002/ejp.564
- The paper
- Perrot, S., & Russell, I. J. (2014). More ubiquitous effects from non‐pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta‐analysis examining six core symptoms. European Journal of Pain. https://doi.org/10.1002/ejp.564
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.